Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2019
Prediction of Tumor Control in <sup>90</sup>Y Radioembolization by Logit Models with PET/CT-Based Dose MetricsYuni K Dewaraja, Theresa Devasia, Ravi K Kaza, et al.
CA: a Cancer Journal for Clinicians|June 23, 2022
Cancer treatment and survivorship statistics, 2022Kimberly D Miller, Leticia Nogueira, Theresa Devasia, et al.
Journal of the National Cancer Institute|July 13, 2024
Prevalence of cancer survivors in the United StatesEmily Tonorezos, Theresa Devasia, Angela B Mariotto, et al.
Abdominal Radiology (New York)|April 19, 2020
Natural history of hepatocellular carcinoma after stereotactic body radiation therapyMishal Mendiratta-Lala, William Masch, Dawn Owen, et al.
Translational Oncology|May 12, 2019
Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver InjuryKyle C Cuneo, Theresa Devasia, Yilun Sun, et al.
EJNMMI Physics|December 1, 2018
Impact of <sup>90</sup>Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolizationJustin K Mikell, Ravi K Kaza, Peter L Roberson, et al.
JNCI Cancer Spectrum|May 26, 2022
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation TherapyKristian D Stensland, Theresa Devasia, Megan E V Caram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2019
Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic CancerKyle C Cuneo, Meredith A Morgan, Vaibhav Sahai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2020
Low-Dose Hsp90 Inhibitor Selectively Radiosensitizes HNSCC and Pancreatic XenograftsRanjit K Mehta, Sanjima Pal, Koushik Kondapi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2020
BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain MetastasesMichelle M Kim, Hemant A Parmar, Matthew Schipper, et al.
Pageof 2